A. Anselmo

Molecular Biology · 2013–2021

A researcher in the Science corpus: 6 papers; trusts 15 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 90 citations into it
• Biomaterials — 71 citations into it; #814 of 2,152 by trust here, #1,095 by citations
• Materials Chemistry — 65 citations into it; #5,354 of 11,513 by trust here, #5,658 by citations
• Biomedical Engineering — 62 citations into it; #9,686 of 10,734 by trust here, #4,640 by citations
• Oncology — 32 citations into it
• Electronic, Optical and Magnetic Materials — 21 citations into it; #1,432 of 2,886 by trust here, #2,744 by citations
• Immunology — 20 citations into it
• Physiology — 6 citations into it

Whom A. Anselmo trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Mark E. Davis
2. S. Mitragotri
3. Vladimir Torchilin
4. J. Champion
5. H. Maeda
6. Y. Barenholz
7. N. Desai
8. L. Kelland
9. Nicholas J. Schork
10. Robby A. Petros

Who trusts A. Anselmo overall

1. Rui Kuai
2. S. Mitragotri
3. Lukasz J. Ochyl

Papers from A. Anselmo's perspective

Ordered by how strongly the researchers A. Anselmo trusts endorse each paper. Same corpus, a different order for every researcher.

1. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics (Nature Biotechnology)
2. Active targeting schemes for nanoparticle systems in cancer therapeutics. (Advanced Drug Delivery Reviews)
3. Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
4. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation (Chemical Society Reviews)
5. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile (Science Translational Medicine)
6. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. (Journal of the American Chemical Society)
7. Nanoparticles and the immune system. (Endocrinology)
8. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles (Molecular Pharmaceutics)
9. Applications of carbon nanotubes in drug delivery. (Current Opinion in Chemical Biology)
10. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis (New England Journal of Medicine)

Their papers

• MoS₂ field-effect transistor for next-generation label-free biosensors. (2014) — 931 citations
• Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium (2013) — 595 citations
• A Review of Clinical Translation of Inorganic Nanoparticles (2015) — 435 citations
• Nanoparticles in the clinic (2016) — 1,116 citations
• The evolution of commercial drug delivery technologies (2021) — 1,037 citations
• Nanoparticles in the clinic: An update (2019) — 1,310 citations